BAY-2925976

• Description:

  BAY-2925976 is an α2C adrenergic receptor (ARα2C) antagonist that can be used for the study of obstructive sleep apnea (OSA) [1].

• UNSPSC:

  12352005

• Target:

  Androgen Receptor

• Type:

  Reference compound

• Related Pathways:

  Vitamin D Related/Nuclear Receptor

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/bay-2925976.html

• Concentration:

  10mM

• Purity:

  99.14

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  C[C@@H]1CCCN(C2CCN(C3=NC=C(C(NCC4=C(F)C=C(F)C=N4)=O)S3)CC2)C1

• Molecular Formula:

  C21H27F2N5OS

• Molecular Weight:

  435.53

• References & Citations:

  [1]The journey to the ARα2C antagonist BAY 2925976 for the treatment of obstructive sleep apnea (OSA) .

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2642235-06-9]